AERIE PHARMACEUTICALS INC's ticker is AERI and the CUSIP is 00771V108. A total of 157 filers reported holding AERIE PHARMACEUTICALS INC in Q3 2022. The put-call ratio across all filers is 0.60 and the average weighting 0.3%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2022 | $719,000 | +221.0% | 47,529 | +59.3% | 0.00% | +100.0% |
Q2 2022 | $224,000 | -55.2% | 29,829 | -45.7% | 0.00% | 0.0% |
Q1 2022 | $500,000 | +287.6% | 54,967 | +199.4% | 0.00% | – |
Q4 2021 | $129,000 | -95.5% | 18,358 | -89.9% | 0.00% | -100.0% |
Q2 2021 | $2,898,000 | -30.4% | 181,018 | -22.3% | 0.01% | -36.4% |
Q1 2021 | $4,164,000 | +716.5% | 233,029 | +2299.1% | 0.01% | +450.0% |
Q2 2017 | $510,000 | -95.6% | 9,713 | -96.2% | 0.00% | -94.9% |
Q1 2017 | $11,482,000 | – | 253,190 | – | 0.04% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
LEVIN CAPITAL STRATEGIES, L.P. | 1,373,542 | $15,658,000 | 1.56% |
DAFNA Capital Management LLC | 289,040 | $3,295,000 | 0.87% |
Integral Health Asset Management, LLC | 250,000 | $2,850,000 | 0.82% |
JACOB ASSET MANAGEMENT OF NEW YORK LLC | 193,266 | $2,203,000 | 0.80% |
PFM Health Sciences, LP | 2,182,684 | $24,883,000 | 0.73% |
DCF Advisers, LLC | 136,501 | $1,556,000 | 0.69% |
DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 2,977,020 | $33,938,000 | 0.66% |
NEXPOINT ASSET MANAGEMENT, L.P. | 309,778 | $3,532,000 | 0.61% |
Rhenman & Partners Asset Management AB | 750,000 | $8,550,000 | 0.60% |
RICE HALL JAMES & ASSOCIATES, LLC | 1,232,600 | $14,052,000 | 0.52% |